Envestnet Portfolio Solutions, Inc. Tg Therapeutics, Inc. Transaction History
Envestnet Portfolio Solutions, Inc.
- $24.4 Billion
- Q2 2025
A detailed history of Envestnet Portfolio Solutions, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Envestnet Portfolio Solutions, Inc. holds 15,089 shares of TGTX stock, worth $417,965. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,089Holding current value
$417,965% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
413Shares Held
87.9MCall Options Held
2.34MPut Options Held
1.93M-
Vanguard Group Inc Valley Forge, PA15.6MShares$432 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$315 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$206 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$90.9 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$78.9 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.02B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...